Country Trust Bank Makes New $163,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Country Trust Bank acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 400 shares of the company’s stock, valued at approximately $163,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Envestnet Asset Management Inc. grew its holdings in shares of HCA Healthcare by 2.3% during the fourth quarter. Envestnet Asset Management Inc. now owns 210,313 shares of the company’s stock valued at $56,927,000 after purchasing an additional 4,784 shares during the last quarter. Personal CFO Solutions LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $262,000. Ossiam grew its position in shares of HCA Healthcare by 14.2% during the fourth quarter. Ossiam now owns 3,782 shares of the company’s stock worth $1,024,000 after acquiring an additional 469 shares during the last quarter. State of Tennessee Treasury Department lifted its position in HCA Healthcare by 15.2% in the 4th quarter. State of Tennessee Treasury Department now owns 96,706 shares of the company’s stock valued at $26,176,000 after purchasing an additional 12,764 shares during the last quarter. Finally, Ethic Inc. increased its stake in shares of HCA Healthcare by 0.6% in the fourth quarter. Ethic Inc. now owns 21,477 shares of the company’s stock valued at $5,813,000 after purchasing an additional 134 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on HCA. Wells Fargo & Company raised their target price on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective on the stock. UBS Group raised their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Finally, Royal Bank of Canada increased their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insiders Place Their Bets

In related news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 in the last three months. Insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 1.1 %

NYSE HCA opened at $378.46 on Wednesday. The stock has a market cap of $99.12 billion, a price-to-earnings ratio of 18.87, a PEG ratio of 1.52 and a beta of 1.67. The firm’s 50 day moving average price is $385.10 and its two-hundred day moving average price is $346.13. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $409.42.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.29 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.70%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.